Lead Like You're Fighting Nazis
June 19, 2013
Not fighting big bad Nazis like the Red Skull? Don't worry, you can still lead like Captain America. You don't even have to dress up in the red, white and blue costume, although it is wonderfully corny... Read More
from Forbes Real Time
Is the NBA Going to Sell Obamcare?
June 19, 2013
As the Miami Heat and San Antonio Spurs battle for the O'Brien Trophy in the NBA Finals, there is another NBA related story with a healthcare twist that deserves to be explored. During a recent... Read More
from Forbes Real Time
Call for overhaul of drug industry business model
June 18, 2013
Pharmaceutical companies need to boost the benefits of drug research by working with regulators and healthcare providers to overhaul the way medicines are approved and paid for, a thinktank backed by... Read More
from FOX News
One Simple Measure for Investing in a Volatile Market
June 18, 2013
from Trefis
The NIH Aims To Develop Drugs That Big Pharma Discarded
June 18, 2013
This morning, the National Institutes of Health awarded $12.7 million to nine academic groups to test potential medicines for diseases including Alzheimer's disease, Duchenne muscular dystrophy, and... Read More
from Forbes Real Time
Consumer Group Urges Caution on Splenda Use
June 18, 2013
category
NYSE:JNJ
,
Market Insight: Financial Articles
Johnson & Johnson (JNJ) higher on buying Aragon
June 18, 2013
Johnson & Johnson (NYSE: JNJ) shares eked higher 0.4% to $85.97, after it announced Monday a definitive agreement to acquire Aragon Pharmaceuticals for an upfront cash payment of $650 million, plus... Read More
from BAYSTREET RSS FEED
Notable ETF Inflow Detected - IVV, XOM, JNJ, CVX
June 18, 2013
Symbols mentioned in this story: IVV, XOM, JNJ, CVX Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
category
ETFs
from ETF Channel
Medivation’s Xtandi Threatened by J&J’s New Acquisition
June 18, 2013
One of the biotech laggards of the year, Medivation (NASDAQ: MDVN) saw a very high volume selloff (-6.78% ?$47.41/share) yesterday after rival Johnson & Johnson (NYSE: JNJ) announced the acquisition of... Read More
from Bio-Wire.Com
Need Income? You Need Covered Calls
June 18, 2013
category
NYSE:JNJ
,
Options 101
Where to put your money for a long, hot summer
June 18, 2013
With U.S. stocks struggling to break new ground and a rise in Treasury yields upsetting the bond market, money managers are recommending a mix of proven blue-chips and exchange-traded products to... Read More
from MarketWatch
Market Wrap: Empire Manufacturing State of Mind; Weyerhaeuser Purchases; Walter Continues Slide
June 17, 2013
Benzinga's M&A Chatter for Monday June 17, 2013
June 17, 2013
Daily Wrap: June 17, 2013
June 17, 2013
Stocks pared earlier gains, as investors grow more nervous every day with regard to the timing of the Federal Reserve decision to reduce bond purchases The Federal Open Market Committee Meeting begins... Read More
category
Stocks
from Market News Video
Bio-Wire Equity Surveillance – Closing Bell 6/17/2013
June 17, 2013
Monday, June 17th, 2013 DJIA: +.73% ?15,179.85 S&P 500: +.76% ?1,639.04 NASDAQ: +.83% ?3,452.13 NASDAQ Biotech: -.81% ?1,817.88 NYSE Arca – Pharma Index: +.30% ?430.35 Big pharma (Mkt Cap $10 B+) +.04%... Read More
from Bio-Wire.Com
Market Wrap for Tuesday, June 17: Stocks Jump to Start Trading Week; Dow Rallies Triple Digits
June 17, 2013
Market Wrap-Up for June 17 (WY, JNJ, LOW, more)
June 17, 2013
Ahead of the Federal Reserve’s two-day FOMC meeting this week, a wave of bullish sentiment flowed through the markets, sending the indices into positive territory early in the day’s session. After... Read More
from Dividend Daily
Markets Advance On Fed Hopes
June 17, 2013
The markets advanced during the midday with the Dow leaping 171 points to 15,241 as investors grew more confidant that the Federal Reserve would maintain its bond buying program. Nasdaq jumped 43... Read More
category
Market News
Midday Movers: ERJ, UTX, MDVN & More
June 17, 2013
from CNBC.com News
J&J to Buy Aragon Pharmaceuticals for $1B
June 17, 2013
category
NYSE:JNJ
,
Market Insight: Financial Articles
Johnson & Johnson Acquires Prostate Cancer Drug
June 17, 2013
This morning, Johnson & Johnson (JNJ) announced it would buy Aragon Pharmaceuticals for as much as $1 billion. Aragon Pharmaceuticals is a privately held company and as part of the deal would receive... Read More
category
Stocks
from Market News Video
By Ransdell Pierson June 17 (Reuters) - Johnson & Johnson said it would pay up to $1 billion for Aragon Pharmaceuticals and its experimental drugs for prostate cancer, bolstering J&J's role in the... Read More
category
companyNews
On Monday, healthcare product company, Johnson & Johnson (JNJ) announced that it will acquire Aragon Pharmaceuticals. Aragon, which is a private company that is currently in a mid-stage clinical trial... Read More
from Dividend Daily
Johnson & Johnson (JNJ) Acquires Privatly-Held Aragon Pharmaceuticals for $650M, Plus Contingencies
June 17, 2013
Johnson & Johnson to buy Aragon for up to $1 billion
June 17, 2013
June 17 (Reuters) - Johnson & Johnson said on Monday that it would buy Aragon Pharmaceuticals, a private company that is running a mid-stage clinical trial for a prostate cancer drug, for $650 million... Read More
category
companyNews
Lower Entry Prices Mean Locking Higher Yields Today
June 16, 2013
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
